EP4157822A1 Heterocyclic SOCE Inhibitors Patent, Apr 15, 2026
Summary
The European Patent Office published application EP4157822A1 for heterocyclic SOCE (Store-Operated Calcium Entry) inhibitors and therapeutic uses thereof. The application names six inventors across six French research institutions including INSERM, CNRS, and Université de Rennes as applicants. The claimed compounds span multiple therapeutic categories including cardiovascular, respiratory, dermatological, musculoskeletal, neurological (including dementia), and anti-inflammatory applications, as indicated by the A61P classification codes. A1 publication kind code confirms the application was published with the European search report.
About this source
GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 63 changes logged to date.
What changed
The EPO published European patent application EP4157822A1 for heterocyclic SOCE inhibitors filed by six French research institutions (INSERM, Université de Brest, Ecole Nationale Supérieure de Chimie de Rennes, Institut National des Sciences Appliquées de Rennes, Université Nangui Abrogoua, and CNRS/Université de Rennes). The application covers therapeutic uses of heterocyclic compounds that inhibit store-operated calcium entry, with claims spanning multiple A61P therapeutic categories from cardiovascular and respiratory conditions to neurological disorders and anti-inflammatory applications.
For pharmaceutical manufacturers and biotech companies researching calcium signaling pathways, this publication establishes a prior art date and territorial scope across 17 designated European Patent Convention member states. Competitors developing SOCE-modulating compounds for similar therapeutic indications should review freedom-to-operate implications. Research institutions may consider this when designing around or licensing programs for calcium channel-targeted drug development.
Archived snapshot
Apr 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SOCE INHIBITORS AND THERAPEUTIC USES THEREOF
Publication EP4157822A1 Kind: A1 Apr 15, 2026
Applicants
Institut National de la Santé et de la
Recherche Médicale (INSERM), Université de Brest, Ecole Nationale Superieure de Chimie de Rennes, Institut National des Sciences Appliquées de
Rennes, Universite Nangui Abrogoua, Centre National de la Recherche Scientifique
(CNRS), Université de Rennes
Inventors
BAZUREAU, Jean Pierre, DAGO, Déliko Camille, VOLI, Lou Anne, MIGNEN, Olivier, BRIGADEAU, Christophe, BEKRO, Yves-Alain
IPC Classifications
C07D 231/12 20060101AFI20230224BHEP C07D 231/56 20060101ALI20230224BHEP C07D 235/06 20060101ALI20230224BHEP C07D 235/10 20060101ALI20230224BHEP C07D 249/08 20060101ALI20230224BHEP C07D 405/12 20060101ALI20230224BHEP A61K 31/415 20060101ALI20230224BHEP A61K 31/416 20060101ALI20230224BHEP A61K 31/4184 20060101ALI20230224BHEP A61K 31/4196 20060101ALI20230224BHEP A61P 7/02 20060101ALI20230224BHEP A61P 1/18 20060101ALI20230224BHEP A61P 9/00 20060101ALI20230224BHEP A61P 11/00 20060101ALI20230224BHEP A61P 11/06 20060101ALI20230224BHEP A61P 17/06 20060101ALI20230224BHEP A61P 19/00 20060101ALI20230224BHEP A61P 19/02 20060101ALI20230224BHEP A61P 21/00 20060101ALI20230224BHEP A61P 25/28 20060101ALI20230224BHEP A61P 29/00 20060101ALI20230224BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.